 |
|
 |
Oramed Pharmaceuticals (OTC:ORMP.OB) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an oral insulin capsule currently in Phase 2 trials, the Company is seeking to revolutionize the treatment of diabetes.
|
Press Releases
October 25, 2011
Oramed Pharmaceuticals Chosen to Present at the Diabetes Technology Meeting (October 27-29, 2011; San Francisco, CA) ... read more »
October 4, 2011
Corporate Profile's CPReports.com Publishes report by RAY DIRKS of RAY DIRKS Research on Oramed Pharmaceuticals ... read more »
January 10, 2012
Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes ... read more »
January 24, 2012
Oramed Pharmaceuticals Granted Australian Patent for an Important Part of the Company's Core Technology in Oral Delivery of Proteins ... read more » |
| Press Center | Terms & Conditions | Privacy Statement | Design and programming by BIGDESIGN Creative Agency | All rights reserved © 2009 Oramed |